| answer text |
<p>The UK committed approximately £71 million to the self-financing facility of COVAX,
which enables high and upper-middle income countries to pool investments in potential
vaccine candidates, and supported its establishment last year. This gives us the option
to buy vaccines for up to 20% of the UK population - approximately 27 million doses.
The Government has separately committed £548 million to the COVAX Advance Market Commitment,
which will distribute 1.2 billion doses of vaccines to developing countries this year.</p><p>
</p><p>In addition, I am proud that as part of our commitment to the G7 to donate
100m doses over the course of the next year, the UK has so far donated over 10 million
doses to those countries most in need, of which over 6 million have gone to COVAX.
Throughout the COVID-19 vaccination programme, vaccine supply and deliveries have
been carefully managed by the Vaccine Taskforce to meet the requirements of the domestic
vaccination programme as well as support other countries’ domestic campaigns. The
recent sharing of 4 million doses with Australia is a good example of this.</p><p>
</p><p>I refer the Hon. Member to the answer I gave her on 3rd March 2021 to Question
<a href="https://questions-statements.parliament.uk/written-questions/detail/2021-02-23/157070"
target="_blank">157070</a>: the UK procured approximately 0.5 million doses of the
Pfizer vaccine through COVAX, which were delivered earlier this year. These doses
helped the NHS deliver our vaccination programme as quickly as possible. No further
doses have been received by the UK from COVAX.</p>
|
|
